Atlas Trials

Doxecitine and Doxribtimine-Expanded Access

Clinical trial NCT06590493 · AVAILABLE

Trial details

NCT number
NCT06590493
Sponsor
UCB BIOSCIENCES, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Thymine Kinase 2 Deficiency

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.